Sykehuset i Vestfold

Running trials

• Not yet recruiting

  Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.

  NCT07757412· Phase 2· Source

• Recruiting

  ARTEMIS - The ARTEMIS Cohort

  NCT07421219· Source

• Recruiting

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  NCT07106762· Phase 2/3· Source

• Recruiting

  Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Trial - Holistic Study

  2023-505573-32-00· Phase 3· Source

• Recruiting

  Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

  NCT06781879· Phase 4· Source

• Recruiting

  Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

  NCT06626022· Phase 3· Source

• Recruiting

  eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity)

  2023-506289-29-00· Phase 4· Source

• Recruiting

  The Norwegian Immunotherapy in Multiple Myeloma Study

  NCT06855121· Source

• Recruiting

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  NCT06152575· Phase 3· Source

• Recruiting

  A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

  NCT06285318· Source

• Active, not recruiting

  Remote Monitoring After Heart Failure

  NCT05447598· Source

• Recruiting

  Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity

  NCT05611697· Source

• Recruiting

  SACK

  2022-501600-10-00· Phase 3· Source

• Recruiting

  Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

  NCT05448547· Phase 3· Source

• Recruiting

  Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer

  NCT04549688· Source

• Recruiting

  A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

  NCT04332822· Phase 3· Source

• Recruiting

  Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial

  NCT03977571· Source

• Active, not recruiting

  BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

  NCT07511517· Source

• Recruiting

  Genetic Study of Amyotrophic Lateral Sclerosis in Norway

  NCT05119387· Source

• Active, not recruiting

  Prevention of Coronary Heart Disease in Morbidly Obese Patients

  NCT00626964· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma4 recruiting
• Prostate cancer3 recruiting
• Bladder cancer2 recruiting
• Obesity2 recruiting
• ALS (motor neurone disease)1 recruiting
• Amyloidosis1 recruiting
• Atrial fibrillation1 recruiting
• Cerebral palsy1 recruiting
• Chronic kidney disease1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Kidney cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· Phase 3· Source

• Completed

  Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

  NCT05742802· Phase 3· Source

• Completed

  The Nordic IBD Treatment Strategy Trial

  NCT05180175· Phase 4· Source

• Completed

  NORDTREAT Prospective Study on Inflammatory Bowel Disease

  NCT05414578· Source

• Completed

  Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

  NCT05166889· Phase 3· Source

• Completed

  The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study

  NCT04122235· Source

Trial sites

• Vestfold Hospital Trust8 trials
• Center for Cancer and Blood Diseases, Vestfold Hospital Trust1 trial
• Morbid Obesity Center, Vestfold Hospital Trust1 trial
• Sykehuset i Vestfold3 trials
• Sykehuset i Vestfold, Avd. Tønsberg0 trials
• Sykehuset i Vestfold (Site 0903)0 trials
• The Morbid Obesity Center, Vestfold Hospital Trust1 trial
• Vestfold Hospital Trust8 trials
• Vestfold Hospital Trust, Department of Neurology1 trial
• Vestfold Hospital Trust (Hospital of Vestfold)2 trials
• Vestfold Hospital Trust (SiV)1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Cerebral palsy8 works · 1 trial
• Down syndrome7 works · 0 trials